Results 91 to 100 of about 14,940 (200)

In vitro and in vivo microbiological evaluations of cefoperazone

open access: yes, 1980
Evaluations of minimum inhibitory concentrations MICs) were carried out with cefoperazone on 35 gram-positive, 60 gram-negative, and 64 anaerobic strains.
COMANDUCCI, Antonella   +4 more
core  

Economic Examination of Cefoperazone Therapy

open access: yes, 1987
Medical records of 1137 patients from 35 hospitals were reviewed to examine the total cost of care for patients receiving cefoperazone as initial therapy compared to a control group receiving alternative agents.
Susan Wyant, Jake Jacobs
core   +1 more source

Research on the treatment of Pseudomonas aeruginosa pneumonia in children by macrolide antibiotics

open access: yesOpen Medicine, 2015
To observe a therapeutic effect of macrolide antibiotics in children with Pseudomonas aeruginosa pneumonia. Fifty-four cases of children with Pseudomonas aeruginosa pneumonia were randomly divided into an observation group (n=30) and a control group (n ...
Huang Xu-qiang   +6 more
doaj   +1 more source

Study on the time-sequential change of acetaldehyde-protein adduct and detection of metabolites of disulfiram-like reaction in rats

open access: yesEgyptian Journal of Forensic Sciences
Background Disulfiram-like reactions are associated with alcohol consumption during the administration of specific drugs, and their diagnosis is a challenge in clinical and forensic medicine.
Ruijiao Lin   +6 more
doaj   +1 more source

Cefoperazone Induced Gastro-intestinal Haemorrhage. A Case Report

open access: yes, 2008
Cefoperazone is a parenteral third generation cephalosporin which is active against many Gram positive and Gram negative organisms. Cefaperazone, like other cephalosporins which contain methyltiotetrazole side chain, can C cause hypoprotrombinaemia and ...
Kale, N.   +8 more
core   +1 more source

Proposal for agar disk diffusion interpretive criteria for susceptibility testing of bovine mastitis pathogens using cefoperazone 30 μg disks

open access: yes, 2016
Cefoperazone is a third generation cephalosporin which is commonly used for bovine mastitis therapy. Bacterial pathogens involved in bovine mastitis are frequently tested for their susceptibility to cefoperazone.
Schwarz, Stefan   +5 more
core   +1 more source

Carbapenem-Sparing Therapy of ESBL- Enterobacterales Pyelonephritis: A Retrospective Comparison of Cefoperazone-Sulbactam and Meropenem [PDF]

open access: yes
Objective: To compare the real-world clinical outcomes, time to clinical cure of patients with Extended-spectrum b-lactamase-producing Enterobacterales (ESBL-E) pyelonephritis who received cefoperazone-sulbactam versus meropenem based on retrospective ...
Samreen Sarfaraz   +5 more
core   +1 more source

Appropriate composites of cefoperazone–sulbactam against multidrug-resistant organisms

open access: yesInfection and Drug Resistance, 2018
Chih-Cheng Lai,1 Chi-Chung Chen,2,3 Ying-Chen Lu,3 Tsuey-Pin Lin,4 Yin-Ching Chuang,2,5 Hung-Jen Tang4,6 1Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, 2Department of Medical Research, Chi Mei Medical Center, Tainan ...
Lai CC   +5 more
doaj  

Montelukast and cefoperazone act as antiquorum sensing and antibiofilm agents against Pseudomonas aeruginosa

open access: yes
Aims Drug repurposing is an attractive strategy to control biofilm-related infectious diseases. In this study, two drugs (montelukast and cefoperazone) with well-established therapeutic applications were tested on Pseudomonas aeruginosa quorum sensing ...
Cerqueira, NMFSA   +5 more
core   +1 more source

EVALUATION OF CEFOPERAZONE/SULBACTAM AND VITAMIN K USE IN PATIENTS WITH BACTERIAL INFECTIONS [PDF]

open access: yes, 2019
Objective: The objectives of this study were to evaluate the effects of Vitamin K use for bleeding or coagulopathies prevention and to assess theoccurrence of drug-related problems in patients receiving cefoperazone/sulbactam.Methods: The prospective ...
SEESIN, THEERAPONG   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy